These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 7661275

  • 1. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
    Lajoie G, Kumar S, Min KW, Silva FG.
    Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
    [Abstract] [Full Text] [Related]

  • 2. [Acute renal failure due to thrombotic microangiopathy associated with Castleman's disease].
    López Montes A, Andrés Mompeán E, Martínez Villaescusa M, Llamas Fuente F, García-Mauriño Guelbenzu ML.
    An Med Interna; 2007 Dec; 24(12):591-4. PubMed ID: 18278998
    [Abstract] [Full Text] [Related]

  • 3. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
    Saiki R, Katayama K, Hirabayashi Y, Oda K, Fujimoto M, Murata T, Nakajima A, Dohi K.
    BMC Nephrol; 2021 Jun 09; 22(1):216. PubMed ID: 34107915
    [Abstract] [Full Text] [Related]

  • 4. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Case report and review of the literature.
    Said R, Tarawneh M.
    Am J Nephrol; 1992 Jun 09; 12(6):466-70. PubMed ID: 1292348
    [Abstract] [Full Text] [Related]

  • 5. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP, Kim DK, Oh DY, Paik JH, Moon KC, Kim S, Kim YS.
    Clin Nephrol; 2011 Feb 09; 75(2):165-70. PubMed ID: 21255547
    [Abstract] [Full Text] [Related]

  • 6. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
    Seida A, Wada J, Morita Y, Baba M, Eguchi J, Nishimoto N, Okino T, Ichimura K, Yoshino T, Makino H.
    Am J Kidney Dis; 2004 Jan 09; 43(1):E3-9. PubMed ID: 14712466
    [Abstract] [Full Text] [Related]

  • 7. Severe polyneuropathy: initial manifestation of Castleman's disease associated with POEMS syndrome.
    Ku A, Lachmann E, Tunkel R, Nagler W.
    Arch Phys Med Rehabil; 1995 Jul 09; 76(7):692-4. PubMed ID: 7605193
    [Abstract] [Full Text] [Related]

  • 8. Intestinal lymphangiectasia associated with angiofollicular lymph node hyperplasia (Castleman's disease).
    Moss SF, Thomas DM, Mulnier C, McGill IG, Hodgson HJ.
    Gut; 1992 Jan 09; 33(1):135-7. PubMed ID: 1740268
    [Abstract] [Full Text] [Related]

  • 9. Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia.
    Tsukamoto Y, Hanada N, Nomura Y, Hiki Y, Kasai K, Shigematsu H, Kobayashi Y.
    Am J Nephrol; 1991 Jan 09; 11(5):430-6. PubMed ID: 1809043
    [Abstract] [Full Text] [Related]

  • 10. A rare case of renal thrombotic microangiopathy associated with Castleman's disease.
    Mutneja A, Cossey LN, Liapis H, Chen YM.
    BMC Nephrol; 2017 Feb 10; 18(1):57. PubMed ID: 28183278
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
    Nishi J, Maruyama I.
    Leuk Lymphoma; 2000 Jul 10; 38(3-4):387-94. PubMed ID: 10830746
    [Abstract] [Full Text] [Related]

  • 12. Castleman's disease associated with pemphigus vulgaris.
    Gili A, Ngan BY, Lester R.
    J Am Acad Dermatol; 1991 Nov 10; 25(5 Pt 2):955-9. PubMed ID: 1761779
    [Abstract] [Full Text] [Related]

  • 13. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
    Montoli A, Minola E, Stabile F, Grillo C, Radaelli L, Spanti D, Luccarelli E, Spata C, Minetti L.
    Am J Nephrol; 1995 Nov 10; 15(2):142-6. PubMed ID: 7733151
    [Abstract] [Full Text] [Related]

  • 14. Fibrillary glomerulonephritis in Castleman's disease.
    Miadonna A, Salmaso C, Palazzi P, Elli A, Braidotti P, Lambertenghi Deliliers G.
    Leuk Lymphoma; 1998 Jan 10; 28(3-4):429-35. PubMed ID: 9517516
    [Abstract] [Full Text] [Related]

  • 15. Idiopathic multicentric Castleman's disease: a systematic literature review.
    Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, Krymskaya VP, Kelleher D, Rubenstein AH, Fajgenbaum DC.
    Lancet Haematol; 2016 Apr 10; 3(4):e163-75. PubMed ID: 27063975
    [Abstract] [Full Text] [Related]

  • 16. Castleman's disease of the neck.
    Chen CC, Jiang RS, Chou G, Wang CP.
    J Chin Med Assoc; 2007 Dec 10; 70(12):556-8. PubMed ID: 18194898
    [Abstract] [Full Text] [Related]

  • 17. A benign course of multicentric Castleman's disease with involvement of the spleen and bone marrow.
    Levo Y, Behar AJ, Blum I, Frish B.
    Eur J Haematol; 1987 Nov 10; 39(5):471-4. PubMed ID: 3691764
    [Abstract] [Full Text] [Related]

  • 18. Castleman's disease associated with myasthenia gravis.
    Day JR, Bew D, Ali M, Dina R, Smith PL.
    Ann Thorac Surg; 2003 May 10; 75(5):1648-50. PubMed ID: 12735602
    [Abstract] [Full Text] [Related]

  • 19. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease.
    Sun PP, Yu XJ, Wang SX, Zhou XJ, Qu L, Zhang F, Ma YY, Liu G, Yang L.
    Nephrology (Carlton); 2020 Feb 10; 25(2):125-134. PubMed ID: 31264312
    [Abstract] [Full Text] [Related]

  • 20. [Transitional type of Castleman's disease manifested as the POEMS syndrome].
    Tomić I, Plavec G, Tasić O, Ristanović A, Cvijanović V.
    Vojnosanit Pregl; 2004 Feb 10; 61(4):439-44. PubMed ID: 15552541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.